繁體版 / 簡體版
 
R&D PORTFOLIO
/ MS-20(CHEMO YOUNG)

MS-20(CHEMO YOUNG)

Indication
Ameliorating fatique and appetite loss associated with cancer chemotheraphy
Ingredient
Organic soybean and probiotics fermentation products
Dosage
4ml twice daily on an empty stomach, after diluting in 100ml of warm water
Status
Approved by Ministry of Health and Welfare(MOHW):available in Taiwan Market
Mechanism
Immune restoration and regulation
  • MS-20 is a mixture of soybean fermentation metabolites which is produced in strictly controlled fermenter and with carefully chosen microorganisms that mimics human intestinal environment.
  • The manufacturing and R&D procedures of Chemo Young follow the international regulations.
  • MS-20 was approved as new drug by MOHW in 2011.
  • MS-20 acts as an immunemodulator and probiotics to improve immunity and inhibit tumor growth.
  • MS-20 is the first and the only oral medication for ameliorating fatigue and appetite loss in patients receiving chemotherapy and thus improve the quality of life.
  • The estimated market of MS-20 in Taiwan will be around 4.5 billion TWD as every year there will be 90,000 new cancer patients. Worldwide, the number of cancer patients will reach 1.4 millions and the medical needs will be over 20 billion USD every year.

MS-20 has also been shown to be anti-PD-1 booster in mice cancer model by increasing effector cytotoxic T cells and inhibiting tumor growth, reducing myeloid-derived suppressor cells (MDSCs).


陕西快乐十分中奖技巧 gpk电子试玩 河内5分彩全天计划稳定 双色球合值走势图 福彩黑龙江36选7开奖结果查询 三公牌教学 im电竞选yb115点xyz 陕西快乐十分老走势图 三分赛车怎么玩法 极速11选5对应开奖号 辽宁快乐12选5基本走势图 超级龙王捕鱼机 百人牛牛能 七位数是七星彩吗 竞彩篮球大小分变化 比特币客户端下载 新疆25选7开奖2018年